B. Riley Securities Downgrades Biote to Neutral, Lowers Price Target to $4
Benzinga Newsdesk 1 year ago
NewsDowngradesPrice TargetAnalyst Ratings
B. Riley Securities analyst Jeff Van Sinderen downgrades Biote (NASDAQ:BTMD) from Buy to Neutral and lowers the price target from $8 to $4.
B. Riley Securities analyst Jeff Van Sinderen downgrades Biote (NASDAQ:BTMD) from Buy to Neutral and lowers the price target from $8 to $4.